Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
4
×
fda
4
×
life sciences
national blog main
boston blog main
boston top stories
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
amgen
biotech
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
detroit blog main
detroit top stories
eli lilly
marc goodman
migraine
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
svb leerink
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
allergan
allopregnanolone
What
drug
4
×
fda
new
4
×
approved
approval
class
medicine
migraine
oks
won
announced
arguments
big
brexanolone
cancer
commercialized
companies
competitors
decades
decision
deeper
depression
devastating
developed
disorder
dna
drugs
eli
fast
fingerprint
genetic
going
headache
late
lilly
make
marks
matter
medicines
meeting
Language
Current search:
drug
×
new
×
drugs
×
fda
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines